NPCS 2015

Page 1

12 JUNE 2015 • OSLO NORWAY

Accelerating Innovations and Advancing Discovery


NPCS 2015 Welcome to the Norwegian Prostate Cancer Symposia 2015 (NPCS 2015), which takes place on the 12th June, 2015 in Oslo, Norway. NPCS 2015 brings together basic, translational, and clinical researchers working on prostate cancer in a forum where the latest advances in the field will be presented by leading international experts. This one day intensive Symposium is to enable clinicians actively involved in treating men with prostate cancer to learn about the latest diagnostic tools, clinical approaches and techniques in managing men with prostate cancer. The meeting is free to Norwegian Clinicians and Researchers - space is limited so register now!

SPEAKERS

CONTACT If you have any questions please contact: Edward Schaeffer M.D. Ph.D edwardschaeffer@gmail.com Web:: www.prostatakreftstiftelsen.no/npcs

Edward M. Schaeffer, M.D., Ph.D. Johns Hopkins Medical

Karol Axcrona, M.D., Ph.D. St. Olavs hospital/NTNU

Jonas Hugosson, M.D., Ph.D. University of Gothenburg

VENUE NPCS 2015 will be held at KS Agenda Meeting Centre (Haakon VIIs gate 9) which is Oslo’s most modern and centrally located conference centre.

Alan W. Partin, M.D., Ph.D. Johns Hopkins Medical

John W. Davis, M.D., FACS The University of Texas

Phuoc Tho Tran, M.D., Ph.D. Johns Hopkins Medical

Sophie FossĂĽ, M.D., Ph.D. Oslo University Hospital

Ashley E. Ross, M.D., Ph.D. Johns Hopkins Medical

Kenneth J. Pienta, M.D Johns Hopkins Medical

Christian P. Pavlovich, M.D. Johns Hopkins Medical

Angelo Michael DeMarzo, M.D., Ph.D. Johns Hopkins Medical

Per Anders Abrahamsson, M.D., Ph.D. Lund University

Web: www.ksagenda.no/en


PROGRAM - JUNE 12, 2015 7:45 INTRODUCTION / WELCOME Dr. Edward Schaeffer

8:00 – 9:00 SESSION 1 8:00-8:15 Demographics of Prostate Cancer in Norway, Dr. Karol Axcrona 8:15-8:45 PSA screening trials: Update from an expert and its future, Professor Jonas Hugosson 8:45 Questions

Nerve Sparing, Dr. Edward Schaeffer Challenging Cases – Large prostate, median Lobe, bulky tumors, Dr. John Davis Extended lymph node dissection, Dr. Karol Axcrona 11:30-11:45 Radical Retropubic Prostatectomy – Can robotics teach an “old dog” new tricks?, Dr. Edward Schaeffer - Bloodless approach to the dorsal vein complex - Nerve sparing with High Anterior release

2:20 – 2:45 Advanced prostate cancer pathology, Dr. Michael Demarzo Prognostic Immunohistochemistry stains – Ki67, PTEN, ERG Mimickers and atypical prostate cancer variants. 2:45 – 3:00 Questions 3:00 – 3:45 Molecular Biomarkers of prostate cancers with lethal potential, Dr. Ashley Ross PTEN, Prolaris, GPS and Decipher- When, where and why? 3:45 – 4:00 Questions

11:45 – 1:00 LUNCH

4:00 – 5:15 SESSION 6 Advanced prostate cancer

9:00 - 9:30 SESSION 2 1:00 – 2:00 SESSION 4 9:00-9:25 Active Surveillance for prostate Cancer – The Johns Hopkins Experience – 19 years and counting, Dr. Alan Partin 9:25-930 Questions

9:30-9:45 BREAK 9:30 – 11:45 SESSION 3 Advanced Surgical Techniques 9:30-9:40 Prostate Anatomy, Dr Edward Schaeffer 9:40-10:30 Extra-peritoneal Robotic Prostatectomy, Dr. Christian Pavlovich - Access and Surgical Approach - Nerve Sparing - Questions 10:30 – 11:30 Transperitoneal Robotic Prostatectomy, Drs. John Davis and Edward Schaeffer

Advanced Radio-therapeutic approaches to manage Prostate Cancer 1:00 – 1:30 IMRT, Dr. Phouc Tran Still the gold standard? How much Hormonal suppression is too much? Proton Beam - Does this costly technology improve outcomes? 1:30-1:50 Radiotherapy of High Risk Prostate Cancer. Survival and Adverse effects., Dr. Sophie Fossa 1:50-2:00 Questions

4:00-5:00 Advances in the management of the disease, Dr. Ken Pienta - Advanced Androgen suppression - The role of Abiaterone and Enzalutamide - Chemotherapy in earlier stage prostate cancer - CHAARTED Use of AR variants in the management of advanced disease 5:00-5:15 Questions

5:15-5:45 SPECIAL LECTURE

2:00 – 3:00 SESSION 5

Prostate cancer - what does the future hold 2025? Prof. Per-Anders Abrahamsson

Prostate Cancer pathology – A critical resource in optimal Prostate Cancer management

CONCLUDING REMARKS Dr. Edward Schaeffer

2:00-2:20 Prostate Cancer pathology basics, Dr. Michael Demarzo ISUP 2005 consensus statement – where do we stand today? Immunohistochemical staining to improve diagnosis


www.prostatakreftstiftelsen.no/npcs


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.